Arvinas (ARVN) Assets Average (2018 - 2026)
Arvinas' (ARVN) quarterly Assets Average came in at $682.7 million in Q1 2026, down 34.75% year-on-year from $1.0 billion in Q1 2025, and down 12.6% quarter-over-quarter from $781.1 million in Q4 2025.
Arvinas (ARVN) Assets Average (2018 - 2026) Analysis & Trends
Arvinas' Assets Average history runs 9 years deep, the most recent figure standing at $682.7 million for Q1 2026.
- On a quarterly basis, Assets Average fell 34.75% year-over-year to $682.7 million in Q1 2026; TTM through Mar 2026 was $682.7 million, a 34.75% decrease from a year earlier, with the FY2025 full-year figure at $904.6 million, down 24.49% from the prior year.
- Assets Average retreated to $682.7 million in Q1 2026 per ARVN's latest filing, from $781.1 million in the prior quarter.
- Across five years, Assets Average topped out at $1.5 billion in Q1 2022 and bottomed at $682.7 million in Q1 2026.
- The 5-year median for Assets Average is $1.2 billion (2023), against an average of $1.1 billion.
- Across the five-year window, Assets Average jumped 119.41% in 2022 and slumped 34.75% in 2026, its largest moves.
- Year by year, Assets Average stood at $1.3 billion in 2022, then fell by 9.24% to $1.2 billion in 2023, then slipped by 4.42% to $1.1 billion in 2024, then tumbled by 30.83% to $781.1 million in 2025, then slipped by 12.6% to $682.7 million in 2026.
- Per Business Quant, the three latest ARVN Assets Average figures stand at $682.7 million (Q1 2026), $781.1 million (Q4 2025), and $876.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 682.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 682.70 Mn |
| Dec 31, 2025 | 781.10 Mn |
| Sep 30, 2025 | 876.80 Mn |
| Jun 30, 2025 | 955.20 Mn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.26 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.07 Bn |
| Jun 30, 2023 | 1.13 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.30 Bn |
| Sep 30, 2022 | 1.37 Bn |
| Jun 30, 2022 | 1.45 Bn |
| Mar 31, 2022 | 1.53 Bn |
| Dec 31, 2021 | 1.59 Bn |
| Sep 30, 2021 | 1.12 Bn |
| Jun 30, 2021 | 662.90 Mn |